A non-lethal full-thickness flame burn produces a seroma beneath the forming eschar thereby promoting Pseudomonas aeruginosa sepsis in mice.
Jerod A BrammerGideon WolfScott M BalibanJessica C AllenMyeongjin ChoiAdrienne R KambourisRaphael SimonGary FiskumWei ChaoKerri LopezCatriona MillerNevil J SinghAlan S CrossPublished in: Journal of burn care & research : official publication of the American Burn Association (2021)
The World Health Organization estimates ~180,000 deaths occur annually from burn-related injuries. Many victims that survive the initial burn trauma succumb to bacterial infections that lead to sepsis during treatment. Although advancements in burn care continue to improve in high-income countries due to their burn centers and advanced research, low and middle-income countries continue to see high frequencies of burn injuries and burn-related deaths due to secondary infections. Bacterial-derived sepsis is the most life-threatening danger for people that survive burn injuries. Here we provide evidence for the first time that a subeschar seroma forms post-burn even in the absence of infection in mice. The seroma fills with a volume estimated at 500 µL of fluid, 25% of the blood supply, free of red blood cells. The seroma fluid supports robust Pseudomonas aeruginosa (PA) growth and contains inflammatory cytokines and chemokines, which recruit immature neutrophils and monocytes to the seroma in the absence of endothelial breakdown. These immune cells fail to contain PA expansion and dissemination. This recruitment of monocytes and immature neutrophils may result in sequestering these critical immune cells away from other tissues during a pivotal time during bacterial dissemination, promoting PA-mediated sepsis.
Keyphrases
- wound healing
- pseudomonas aeruginosa
- acute kidney injury
- intensive care unit
- septic shock
- cystic fibrosis
- healthcare
- type diabetes
- insulin resistance
- metabolic syndrome
- high fat diet induced
- adipose tissue
- escherichia coli
- chronic pain
- health insurance
- candida albicans
- optical coherence tomography
- pain management
- quality improvement
- peripheral blood